The Inherited Basis of Diabetes Mellitus: Implications for the Genetic Analysis of Complex Traits

Annual Review of Genomics and Human Genetics

Volumn 4, Issue , 2003, Pages 257-291

  Florez, Jose C ^a,b,c   Hirschhorn, Joel ^b,c,d   Altshuler, David ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; DISEASE CLASSIFICATION; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC TRAIT; HERITABILITY; INHERITANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN GENE; MATURITY ONSET DIABETES MELLITUS; MONOGENIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; REVIEW;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS);

EID: 0242524453     PISSN: 15278204     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genom.4.070802.110436     Document Type: Review

References (196)

1. Agarwal AK, Arioglu E, De Almeida S, Akkoc N, Taylor SI, et al. 2002. AG-PAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat. Genet. 31:21-23
2. Altshuler D, Daly M, Kruglyak L. 2000. Guilt by association. Nat. Genet. 26:135-37
3. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, et al. 2000. The common PPARgamma Pro12A1a polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26:76-80
4. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, et al. 2002. Projection of an immunological self shadow within the thymus by the Aire protein. Science 298:1395-401
5. Ardlie K, Liu-Cordero SN, Eberle MA, Daly M, Barrett J, et al. 2001. Lower-than-expected linkage disequilibrium between tightly linked markers in humans suggests a role for gene conversion. Am. J. Hum. Genet. 69:582-89
6. Ardlie KG, Lunetta KL, Seielstad M. 2002. Testing for population subdivision and association in four case-control studies. Am. J. Hum. Genet 71:1478-80
7. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, et al. 2000. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J. Clin. Invest. 106:R69-73
8. Barnett AH, Eff C, Leslie RD, Pyke DA. 1981. Diabetes in identical twins. A study of 200 pairs. Diabetologia 20:87-93
9. Barrett TG, Bundey SE, Macleod AF. 1995. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DID-MOAD) syndrome. Lancet 346:1458-63
10. Bektas A, Suprenant ME, Wogan LT, Plengvidhya N, Rich SS, et al. 1999. Evidence of a novel type 2 diabetes locus 50 cM centromeric to NIDDM2 on chromosome 12q. Diabetes 48:2246-51
11. Bell GI, Horita S, Karam JH. 1984. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 33:176-83
12. Bell GI, Pictet RL, Rutter WJ, Cordell B, Tischer E, Goodman HM. 1980. Sequence of the human insulin gene. Nature 284:26-32
13. Bell GI, Selby MJ, Rutter WJ. 1982. The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences. Nature 295:31-35
14. Bell GI, Xiang K, Newman MV, Wu SH, Wright LJ, et al. 1991. Gene for non-insulin dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc. Natl. Acad. Sci. USA 88:1884-88
15. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, et al. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20-21
16. Bennett ST, Todd JA. 1996. Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu. Rev. Genet. 30:343-70
17. Bowden DW, Gravius TC, Akots G, Fajans SS. 1992. Identification of genetic markers flanking the locus for maturity-onset diabetes of the young on human chromosome 20. Diabetes 41:88-92
18. Bowden DW, Sale M, Howard TD, Qadri A, Spray BJ, et al. 1997. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 46:882-86
19. Busfield F, Duffy DL, Resting JB, Walker SM, Lovelock PK, et al. 2002. A genomewide search for type 2 diabetes susceptibility genes in indigenous Australians. Am. J. Hum. Genet. 70:349-57
20. Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, et al. 1996. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423-27
21. Cao H, Hegele RA. 2000. Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 9:109-12
22. Cardon LR, Bell JI. 2001. Association study designs for complex diseases. Nat. Rev. Genet. 2:91-99
23. Cassell PG, Jackson AE, North BV, Evans JC, Syndercombe-Court D, et al. 2002. Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians. Diabetes 51:1622-28
24. CDC. 1999. Diabetes Surveillance Report. Atlanta: S. Dep. Health Hum. Serv., PHS
25. Cereghini S. 1996. Liver-enriched transcription factors and hepatocyte differentiation. FASEB J. 10:267-82
26. Chiu KC, Province MA, Dowse GK, Zimmet PZ, Wagner G, et al. 1992. A genetic marker at the glucokinase gene locus for type 2 (non-insulin-dependent) diabetes mellitus in Mauritian Creoles. Diabetologia 35:632-38
27. Clement K, Hercberg S, Passinge B, Galan P, Varroud-Vial M, et al. 2000. The Pro115Gln and Pro12A1a PPAR gamma gene mutations in obesity and type 2 diabetes. Int. J. Obes. Relat. Metab. Disord. 24:391-93
28. Concannon P, Gogolin-Ewens KJ, Hinds DA, Wapelhorst B, Morrison VA, et al. 1998. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat. Genet. 19:292-96
29. Consortium F-GA. 1997. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat. Genet. 17:399-403
30. Copeman JB, Cucca F, Hearne CM, Cornall RJ, Reed PW, et al. 1995. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat. Genet. 9:80-85
31. Cox NJ, Frigge M, Nicolae DL, Concannon P, Hanis CL, et al. 1999. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat. Genet. 21:213-15
32. Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, et al. 2001. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am. J. Hum. Genet. 69:820-30
33. Cudworth AG, Woodrow JC. 1974. Letter: HL-A antigens and diabetes mellitus. Lancet 2:1153
34. Dahlman I, Eaves IA, Kosoy R, Morrison VA, Heward J, et al. 2002. Parameters for reliable results in genetic association studies in common disease. Nat. Genet. 30:149-50
35. Daimon M, Oizumi T, Saitoh T, Kameda W, Yamaguchi H, et al. 2002. Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. Diabetes Res. Clin. Pract. 56:147-52
36. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, et al. 1994. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130-36
37. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, et al. 1998. A Pro12A1a substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 20:284-87
38. Delepine M, Pociot F, Habita C, Hashimoto L, Froguel P, et al. 1997. Evidence of a non-MHC susceptibility locus in type I diabetes linked to HLA on chromosome 6. Am. J. Hum. Genet. 60:174-87
39. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, et al. 1997. CTLA4 Alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 82:143-46
40. Douglas JA, Erdos MR, Watanabe RM, Braun A, Johnston CL, et al. 2001. The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences. Diabetes 50:886-90
41. Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, et al. 1999. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am. J. Hum. Genet. 64:1127-40
42. Eckenrode S, Marron MP, Nicholls R, Yang MCK, Yang JJ, et al. 2000. Fine-mapping of the type 1 diabetes locus (IDDM4) on chromosome 11q and evaluation of two candidate genes (FADD and GALN) by affected sibpair and linkage-disequilibrium analyses. Hum. Genet. 106:14-18
43. Ehm MG, Karnoub MC, Sakul H, Gottschalk K, Holt DC, et al. 2000. Genomewide search for type 2 diabetes susceptibility genes in four American populations. Am. J. Hum. Genet. 66:1871-81
44. Ek J, Andersen G, Urhammer SA, Gæde PH, Drivsholm T, et al. 2001. Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia 44: 2220-26
45. Elbein SC, Chu W, Ren Q, Hemphill C, Schay J, et al. 2002. Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. J. Clin. Endocrinol. Metab. 87:650-54
46. Elbein SC, Hoffman MD, Matsutani A, Permutt MA. 1992. Linkage analysis of GLUT1 (HepG2) and GLUT2 (liver/islet) genes in familial NIDDM. Diabetes 41:1660-67
47. Elbein SC, Hoffman MD, Teng K, Leppert MF, Hasstedt SJ. 1999. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 48:1175-82
48. Evans JC, Frayling TM, Cassell PG, Saker PJ, Hitman GA, et al. 2001. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am. J. Hum. Genet. 69:544-52
49. Fajans SS, Bell GI, Polonsky KS. 2001. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med. 345:971-80
50. Fajans SS, Conn JW. 1960. Tolbutamide-induced improvement in carbohydrate tolerance of young people with mild diabetes mellitus. Diabetes 9:83
51. Feder J, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy D, et al. 1996. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13:399-408
52. Fernandez-Real JM, Vendrell J, Baiget M, Gimferrer E, Ricart W. 1999. C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes. Diabetes Care 22:525-26
53. Field LL. 2002. Genetic linkage and association studies of type I diabetes: challenges and rewards. Diabetologia 45:21-35
54. Field LL, Tobias R, Magnus T. 1994. A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin-dependent diabetes mellitus. Nat. Genet. 8:189-94
55. Field LL, Tobias R, Thomson G, Plon S. 1996. Susceptibility to insulin-dependent diabetes mellitus maps to a locus (IDDM11) on human chromosome 14q24.3-q31. Genomics 33:1-8
56. Fingerlin TE, Erdos MR, Watanabe RM, Wiles KR, Stringham HM, et al. 2002. Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. Diabetes 51:1644-48
57. Froguel P, Vaxillaire M, Sun F, Velho G, Zouali H, et al. 1992. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 356:162-64
58. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, et al. 1993. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N. Engl. J. Med. 328:697-702
59. Fullerton SM, Bartoszewicz A, Ybazeta G, Horikawa Y, Bell GI, et al. 2002. Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus. Am. J. Hum. Genet. 70:1096-106
60. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. 2002. The structure of haplotype blocks in the human genome. Science 296:2225-29
61. Ghosh S, Watanabe RM, Hauser ER, Valle T, Magnuson VL, et al. 1999. Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc. Natl. Acad. Sci. USA 96:2198-203
62. Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL, et al. 2000. The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am. J. Hum. Genet. 67:1174-85
63. Gloyn AL, Hashim Y, Ashcroft SJ, Ashfield R, Wiltshire S, Turner RC. 2001. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53). Diabetes Med. 18:206-12
64. Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, et al. 2003. Large-scale association studies of variants in genes encoding the pancreatic {beta}-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52:568-72
65. Gough SC, Saker PJ, Pritchard LE, Merriman TR, Merriman ME, et al. 1995. Mutation of the glucagon receptor gene and diabetes mellitus in the UK: association or founder effect? Hum. Mol. Genet. 4:1609-12
66. National Diabetes Data Group. 1995. Diabetes in America. NIH Publication No. 95-1468. Bethesda, MD: Natl. Inst. Diabetes Dig. Kidney Dis.
67. Hager J, Hansen L, Vaisse C, Vionnet N, Philippi A, et al. 1995. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nat. Genet. 9:299-304
68. Haneda M, Chan SJ, Kwok SCM, Rubenstein AH, Steiner DF. 1983. Studies on mutant human insulin genes: identification and sequence analysis of a gene encoding (ser-B24) insulin. Proc. Natl. Acad. Sci. USA 80:6366-70
69. Hani EH, Boutin P, Durand E, Inoue H, Permutt MA, et al. 1998. Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia 41:1511-15
70. Hani EH, Clement K, Velho G, Vionnet N, Hager J, et al. 1997. Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians. Diabetes 46:688-94
71. Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, et al. 1996. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2 [see comments]. Nat. Genet. 13:161-66
72. Hansen L, Echwald SM, Hansen T, Urhammer SA, Clausen JO, Pedersen O. 1997. Amino acid polymorphisms in the ATP-regulatable inward rectifier Kir6.2 and their relationships to glucose-and tolbutamide-induced insulin secretion, the insulin sensitivity index, and NIDDM. Diabetes 46:508-12
73. Hansen T, Echwald SM, Hansen L, Moller AM, Almind K, et al. 1998. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes 47: 598-605
74. Hanson RL, Ehm MG, Pettitt DJ, Prochazka M, Thompson DB, et al. 1998. An autosomal genomic scan for loci linked to type II diabetes mellitus and bodymass index in Pima Indians. Am. J. Hum. Genet. 63:1130-38
75. Hara K, Okada T, Tobe K, Yasuda K, Mori Y, et al. 2000. The Pro12A1a polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem. Biophys. Res. Commun. 271:212-16
76. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, et al. 1998. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. Diabetes Care 21:518-24
77. Hart LM, de Knijff P, Dekker JM, Stolk RP, Nijpels G, et al. 1999. Variants in the sulphonylurea receptor gene: association of the exon 16-3t variant with Type II diabetes mellitus in Dutch Caucasians. Diabetologia 42:617-20
78. Hashimoto L, Habita C, Beressi JP, Delepine M, Besse C, et al. 1994. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 371:161-64
79. Hasstedt SJ, Ren Q-F, Teng K, Elbein SC. 2001. Effect of the peroxisome proliferator-activated receptor-{gamma}2 Pro12A1a variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds. J. Clin. Endocrinol. Metab. 86:536-41
80. Hebinck J, Hardt C, Schols L, Vorgerd M, Briedigkeit L, et al. 2000. Heterozygous expansion of the GAA tract of the X25/frataxin gene is associated with insulin resistance in humans. Diabetes 49:1604-47
81. Hegele RA, Cao H, Harris SB, Zinman B, Hanley AJG, Anderson CM. 2000. Peroxisome proliferator-activated receptor-{gamma}2 P12A and type 2 diabetes in Canadian Oji-Cree. J. Clin. Endocrinol. Metab. 85:2014-19
82. Hegele RA, Harris SB, Zinman B, Hanley AJG, Cao H. 2001. Absence of association of type 2 diabetes with CAPN10 and PC-1 polymorphisms in Oji-Cree. Diabetes Care 24:1498-99
83. Hirschhorn JN. 2003. Genetic epidemiology of type 1 diabetes. Pediatr. Diabetes. In press
84. Hirschhorn JN, Altshuler D. 2002. Once and again-issues surrounding replication in genetic association studies. J. Clin. Endocrinol. Metab. 87:4438-41
85. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. 2002. A comprehensive review of genetic association studies. Genet. Med. 4:45-61
86. Hitman GA, Tarn AC, Winter RM, Drummond V, Williams LG, et al. 1985. Type 1 (insulin-dependent) diabetes and a highly variable locus close to the insulin gene on chromosome 11. Diabetologia 28:218-22
87. Hodge SE, Neiswanger K, Spence MA, Sparkes MC, Terasaki PI, et al. 1981. Close genetic linkage between diabetes mellitus and Kidd blood group. Lancet 2:893-95
88. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, et al. 1997. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat. Genet. 17:384-85
89. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, et al. 2000. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26:163-75
90. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC. 1998. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Diabetes 47:821-30
91. Inoue H, Ferrer J, Warren-Perry M, Zhang Y, Millns H, et al. 1997. Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes 46:502-7
92. Inoue H, Ferrer J, Welling CM, Elbein SC, Hoffman M, et al. 1996. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians. Diabetes 45:825-31
93. Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, et al. 1998. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat. Genet. 20:143-48
94. Jackson RS, Creemers JWM, Ohagi S, Raffin-Sanson M-L, Sanders L, et al. 1997. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 16:303-6
95. Ji L, Malecki M, Warram JH, Yang Y, Rich SS, Krolewski AS. 1997. New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 46:876-81
96. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, et al. 2001. Haplotype tagging for the identification of common disease genes. Nat. Genet. 29 233-37
97. Jonsson J, Carlsson L, Edlund T, Edlund H. 1994. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371:606-9
98. Kadowaki T, Bevins CL, Cama A, Ojamaa K, Marcus-Samuels B, et al. 1988. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 240:787-90
99. Kissebah AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, et al. 2000. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc. Natl. Acad. Sci. USA 97:14478-83
100. Kyvik KO, Green A, Beck-Nielsen H. 1995. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. Br. Med. J. 311:913-17
101. Lander E, Kruglyak L. 1995. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11:241-47
102. Lei HH, Chen MH, Yang WS, Chiu MC, Chen MC, et al. 2000. Peroxisome proliferator-activated receptor gamma 2 Pro12A1a gene variant is strongly associated with larger body mass in the Taiwanese. Metabolism 49:1267-70
103. Lepretre F, Vionnet N, Budhan S, Dina C, Powell KL, et al. 1998. Genetic studies of polymorphisms in ten non-insulin-dependent diabetes mellitus candidate genes in Tamil Indians from Pondichery. Diabetes Metab. 24:244-50
104. Li SR, Baroni MG, Oelbaum RS, Stock J, Galton DJ. 1988. Association of genetic variant of the glucose transporter with non-insulin-dependent diabetes mellitus. Lancet 2:368-70
105. Lindgren CM, Mahtani MM, Widén E, McCarthy MI, Daly MJ, et al. 2002. Genomewide search for type 2 diabetes susceptibility loci in Finnish families: The Botnia study. Am. J. Hum. Genet. 70:509-16
106. Lohmueller K, Pearce CL, Pike M, Lander ES, Hirschhorn JN. 2003. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33:177-82
107. Louet J-F, Hayhurst G, Gonzalez FJ, Girard J, Decaux J-F. 2002. The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyl-transferase I gene expression by cAMP in combination with HNF4alpha and cAMP-response element-binding protein (CREB). J. Biol. Chem. 277:37991-8000
108. Luo D-F, Buzzetti R, Rotter JI, Maclaren NK, Raffel LJ, et al. 1996. Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5 and IDDM8. Hum. Mol. Genet. 5:693-98
109. Luo TH, Zhao Y, Li G, Yuan WT, Zhao JJ, et al. 2001. A genome-wide search for type II diabetes susceptibility genes in Chinese Hans. Diabetologia 44:501-6
110. Lynn S, Evans JC, White C, Frayling TM, Hattersley AT, et al. 2002. Variation in the calpain-10 gene affects blood glucose levels in the British population. Diabetes 51:247-50
111. Magre J, Delepine M, Khallouf E, Gedde-Dahl TJ, Van Maldergem L, et al. 2001. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat. Genet. 28:365-70
112. Mahtani MM, Widen E, Lehto M, Thomas J, McCarthy M, et al. 1996. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat. Genet. 14:90-94
113. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, et al. 1999. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat. Genet. 23:323-28
114. Malecki MT, Moczulski DK, Klupa T, Wanic K, Cyganek K, et al. 2002. Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. Eur. J. Endocrinol. 146:695-99
115. Mancini FP, Vaccaro O, Sabatino L, Tufano A, Rivellese AA, et al. 1999. Pro12A1a substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes 48:1466-68
116. Marron MP, Raffel LJ, Garchon H-J, Jacob CO, Serrano Rios M, et al. 1997. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum. Mol. Genet. 6:1275-82
117. Marron MP, Zeidler A, Raffel LJ, Eckenrode SE, Yang JJ, et al. 2000. Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes 49:492-99
118. McCarthy MI, Hitman GA, Hitchins M, Riikonen A, Stengard J, et al. 1994. Glucokinase gene polymorphisms: a genetic marker for glucose intolerance in a cohort of elderly Finnish men. Diabetes Med. 11:198-204
119. Mein CA, Esposito L, Dunn MG, Johnson GC, Timms AE, et al. 1998. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat. Genet. 19:297-300
120. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Auwerx J, et al. 2000. Impact of the peroxisome proliferator activated receptor gamma2 Pro12A1a polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int. J. Obes. Relat. Metab. Disord. 24: 195-99
121. Meirhaeghe A, Helbecque N, Cottel D, Arveiler D, Ruidavets JB, et al. 2001. Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study. Am. J. Hum. Genet. 101:4-8
122. Merriman TR, Cordell HJ, Eaves IA, Danoy PA, Coraddu F, et al. 2001. Suggestive evidence for association of human chromosome 18q12-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases. Diabetes 50:184-94
123. Moczulski DK, Grzelczak Z, Gawlik B. 2001. Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy. Diabetes Care 24:1187-91
124. Moller DE, Flier JS. 1988. Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (type A insulin resistance). N. Engl. J. Med. 319:1526-29
125. Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, et al. PGC-1alpha responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. In press
126. Morahan G, Huang D, Ymer SI, Cancilia MR, Stephen K, et al. 2001. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat. Genet. 27:218-21
127. Mori H, Ikegami H, Kawaguchi Y, Seino S, Yokoi N, et al. 2001. The Pro12 → A1a substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 50:891-94
128. Mori Y, Otabe S, Dina C, Yasuda K, Populaire C, et al. 2002. Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate loci on 7p and 11p. Diabetes 51:1247-55
129. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, et al. 1997. Positional cloning of the APECED gene. Nat. Genet. 17:393-98
130. Nakagawa Y, Kawaguchi Y, Twells RCJ, Muxworthy C, Hunter KMD, et al. 1998. Fine mapping of the diabetes-susceptibility locus, IDDM4, on chromosome 11q13. Am. J. Hum. Genet. 63:547-56
131. Nerup JP, Platz P, Andersen OO, Christy M, Lyngsoe J, et al. 1974. HL-A antigens and diabetes mellitus. Lancet 2:864-66
132. Newman B, Selby JV, King M-C, Slemenda C, Fabsitz R, Friedman GD. 1987. Concordance for Type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30:763-68
133. Nielsen E-MD, Hansen L, Carstensen B, Echwald SM, Drivsholm T, et al. 2003. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 52:573-77
134. Nisticò L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, et al. 1996. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum. Mol. Genet. 5:1075-80
135. Oh EY, Min KM, Chung JH, Min Y-K, Lee M-S, et al. 2000. Significance of Pro12A1a mutation in peroxisome proliferator-activated receptor-{gamma}2 in Korean diabetic and obese subjects. J. Clin. Endocrinol. Metab. 85:1801-4
136. Ohta Y, Tanizawa Y, Inoue H, Hosaka T, Ueda K, et al. 1998. Identification and functional analysis of sulfonylurea receptor 1 variants in Japanese patients with NIDDM. Diabetes 47:476-81
137. Parker A, Meyer J, Lewitzky S, Rennich JS, Chan G, et al. 2001. A gene conferring susceptibility to type 2 diabetes in conjunction with obesity is located on chromosome 18p11. Diabetes 50:675-80
138. Permutt MA, Wasson JC, Suarez BK, Lin J, Thomas J, et al. 2001. A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population. Diabetes 50:681-85
139. Petersen KF, Shulman GI. 2002. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am. J. Cardiol. 90:11G-8G
140. Platz P, Jakobsen BK, Morling N, Ryder LP, Svejgaard A, et al. 1981. HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus. Diabetologia 21:108-15
141. Pontiroli AE, Capra F, Veglia F, Ferrari M, Xiang KS, et al. 1996. Genetic contribution of polymorphism of the GLUT1 and GLUT4 genes to the susceptibility to type 2 (non-insulin-dependent) diabetes mellitus in different populations. Acta Diabetologica 33:193-97
142. Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H. 1999. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-a population-based twin study. Diabetologia 42:139-45
143. Pugliese A, Zeller M, Fernandez AJ, Zalcberg LJ, Bartlett RJ, et al. 1997. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 15:293-97
144. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. 1998. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829-39
145. Rasmussen SK, Urhammer SA, Berglund L, Jensen JN, Hansen L, et al. 2002. Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes 51:3561-67
146. Redondo MJ, Fain PR, Eisenbarth GS. 2001. Genetics of type 1A diabetes. Rec. Prog. Horm. Res. 56:69-89
147. Reed P, Cucca F, Jenkins S, Merriman M, Wilson A, et al. 1997. Evidence for a type 1 diabetes susceptibility locus (IDDM10) on human chromosome 10p11-q11. Hum. Mol. Genet. 6:1011-16
148. Ringel J, Engeli S, Distler A, Sharma AM. 1999. Pro12A1a missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus. Biochem. Biophys. Res. Commun. 254:450-53
149. Risch N, Merikangas K. 1996. The future of genetic studies of complex human diseases. Science 273:1516-17
150. Rissanen J, Markkanen A, Karkkainen P, Pihlajamaki J, Kekalainen P, et al. 2000. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care 23:70-73
151. Robbins DC, Blix PM, Rubenstein AH, Kanazawa Y, Kosaka K, Tager HS. 1981. A human proinsulin variant at arginine 65. Nature 291:679-81
152. Rotter JI, Anderson CE, Rubin R, Congleton JE, Terasaki PI, Rimoin DL. 1983. HLA genotypic study of insulin-dependent diabetes the excess of DR3/DR4 heterozygotes allows rejection of the recessive hypothesis. Diabetes 32:169-74
153. Sakura H, Wat N, Horton V, Millns H, Turner RC, Ashcroft FM. 1996. Sequence variations in the human Kir6.2 gene, a subunit of the beta-cell ATP-sensitive K-channel: no association with NIDDM in white Caucasian subjects or evidence of abnormal function when expressed in vitro. Diabetologia 39:1233-36
154. Salonen JT, Tuomainen TP, Kontula K. 2000. Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study. Br. Med. J. 320:1706-7
155. Schwanstecher C, Meyer U, Schwanstecher M. 2002. KIR6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K+ channels. Diabetes 51:875-79
156. Shackleton S, Lloyd DJ, Jackson SN, Evans R, Niermeijer MF, et al. 2000. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat. Genet. 24:153-56
157. Shaw JT, Lovelock PK, Resting JB, Cardinal J, Duffy D, et al. 1998. Novel susceptibility gene for late-onset NIDDM is localized to human chromosome 12q. Diabetes 47:1793-96
158. Sheehy MJ, Scharf SJ, Rowe JR, Neme de Gimenez MH, Meske LM, et al. 1989. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J. Clin. Invest. 83:830-35
159. Singal DP, Blajchman MA. 1973. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 22:429-32
160. Spiegelman BM. 1998. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-14
161. Spielman RS, Baker L, Zmijewski CM. 1980. Gene dosage and suceptibility to insulin-dependent diabetes. Ann. Hum. Genet. 44:135-50
162. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52:506-16
163. Sramkova D, Kunesova M, Hainer V, Hill M, Vcelak J, Bendlova B. 2002. Is a Pro12A1a polymorphism of the PPAR{gamma}2 gene related to obesity and type 2 diabetes mellitus in the Czech population? Ann. NY Acad. Sci. 967:265-73
164. Stoffers DA, Ferrer J, Clarke WL, Habener JF. 1997. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat. Genet. 17:138-39
165. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. 1997. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 15:106-10
166. Tabor HK, Risch NJ, Myers RM. 2002. Opinion: Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat. Rev. Genet. 3:391-97
167. Takekawa K, Ikegami H, Fukuda M, Ueda H, Kawaguchi Y, et al. 1994.Early-onset type 2 (non-insulin-dependent) diabetes mellitus is associated with glucokinase locus, but not with adenosine deaminase locus, in the Japanese population. Diabetes Res. Clin. Pract. 23:141-46
168. Tao T, Tanizawa Y, Matsutani A, Matsubara A, Kaneko T, Kaku K. 1995. HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects. Diabetologia 38:942-47
169. Thomas PM, Cote GJ, Wohlik N, Haddad B, Mathew PM, et al. 1995. Mutations in the sulfonylurea receptor gene in familial hyperinsulinemic hypoglycemia of infancy. Science 268:426-29
170. β gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599-604
171. Todd JA, Mijovic C, Fletcher J, Jenkins D, Bradwell AR, Barnett AH. 1989. Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature 338:587-89
172. Tsai HJ, Sun G, Weeks DE, Kaushal R, Wolujewicz M, et al. 2001. Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association. Am. J. Hum. Genet. 69: 1236-44
173. 171a. Ueda H, Howson JMM, Esposito L, Heward J, Snook H, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature doi:10.1038/nature01621
174. Ullrich A, Dull TJ, Gray A, Brosius J, Sures I. 1980. Genetic variation in the human insulin gene. Science 209:612-14
175. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, et al. 1997. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet. 15:289-92
176. Vafiadis P, Ounissi-Benkalha H, Palumbo M, Grabs R, Rousseau M, et al. 2001. Class III alleles of the variable number of tandem repeat insulin polymorphism associated with silencing of thymic insulin predispose to type 1 diabetes. J. Clin. Endocrinol. Metab. 86:3705-10
177. van den Ouweland JM, Lemkes HH, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, et al. 1992. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat. Genet. 1:368-71
178. Vaxillaire M, Boccio V, Philippi A, Vigouroux C, Terwilliger J, et al. 1995. A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nat. Genet. 9:418-23
179. Veijola R, Knip M, Puukka R, Reijonen H, Cox DW, Ilonen J. 1997. The immunoglobulin heavy-chain variable region in insulin-dependent diabetes mellitus: affected-sib-pair analysis and association studies. Am. J. Hum. Genet. 59:462-70
180. Verge CF, Vardi P, Babu S, Bao F, Erlich HA, et al. 1998. Evidence for oligogenic inheritance of type 1 diabetes in a large bedouin arab family. J. Clin. Invest. 102:1569-75
181. Vionnet N, Hani El H, Dupont S, Gallina S, Francke S, et al. 2000. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am. J. Hum. Genet. 67:1470-80
182. Wacholder S, Rothman N, Caporaso N. 2002. Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol. Biomark. Prev. 11:513-20
183. Wang H, Chu W, Das SK, Ren Q, Hasstedt SJ, Elbein SC. 2002. Liver pyruvate kinase polymorphisms are associated with type 2 diabetes in Northern European Caucasians. Diabetes 51: 2861-65
184. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27:18-20
185. Wiltshire S, Hattersley AT, Hitman GA, Walker M, Levy JC, et al. 2001. A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): Analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am. J. Hum. Genet. 69:553-69
186. Winter W, Maclaren N, Riley W, Clarke D, Kappy M, Spillar R. 1987. Maturity-onset diabetes of youth in black Americans. N. Engl. J. Med. 316:285-91
187. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, et al. 1999. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115-24
188. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, et al. 1996. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 384:458-60
189. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, et al. 1996. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 384:455-58
190. Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, et al. 1997. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 7:843-46
191. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, et al. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131-38
192. Yoshida K, Furihata K, Takeda S, Nakamura A, Yamamoto K, et al. 1995. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat. Genet. 9:267-72
193. Yoshimasa Y, Seino S, Whittaker J, Kakehi T, Kosaki A, et al. 1988. Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing. Science 240:784-87
194. Zamani M, Pociot F, Raeymaekers P, Nerup J, Cassiman J-J. 1996. Linkage of type I diabetes to 15q26 (IDDM3) in the Danish population. Hum. Genet. 98:491-96
195. Zhu X, Cooper RS, Luke A, Chen G, Wu X, et al. 2002. A genome-wide scan for obesity in African-Americans. Diabetes 51:541-44
196. Zouali H, Haiti EH, Philippi A, Vionnet N, Beckmann JS, et al. 1997. A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum. Mol. Genet. 6:1401-8